Semaglutide is non-inferior to placebo for cardiovascular...

Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes

Campbell-Scherer, Denise
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Evidence Based Medicine
DOI:
10.1136/ebmed-2016-110652
Date:
April, 2017
File:
PDF, 97 KB
english, 2017
Conversion to is in progress
Conversion to is failed